| 25 May 2026 |
KPV |
4.0 |
20mg |
22.7mg |
+13.6% |
99.09% |
Lab F |
| 25 May 2026 |
P21 |
5.3 |
30mg |
29.3mg |
-2.3% |
98.70% |
Lab D |
| 25 May 2026 |
Prostamax |
4.4 |
2mg |
2.3mg |
+16.2% |
99.36% |
Lab A |
| 24 May 2026 |
Equipoise (Boldenone Undecylenate) |
4.0 |
200mg/ml |
217.6mg/ml |
+8.8% |
97.04% |
Lab G |
| 24 May 2026 |
HMG |
4.0 |
50mg |
49.6mg |
-0.7% |
96.95% |
Lab C |
| 24 May 2026 |
Letrozole |
5.9 |
50mg |
51.3mg |
+2.6% |
98.65% |
Lab B |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
4.0 |
20mg |
22.7mg |
+13.5% |
97.79% |
Lab G |
| 24 May 2026 |
Halotestin (Fluoxymesterone) |
4.0 |
25mg |
30.2mg |
+20.8% |
95.06% |
Lab A |
| 24 May 2026 |
Pinealon |
4.6 |
10mg |
10.3mg |
+3.0% |
99.58% |
Lab E |
| 24 May 2026 |
PTD-DBM |
5.5 |
15mg |
18.7mg |
+24.8% |
95.18% |
Lab D |
| 23 May 2026 |
DSIP |
4.6 |
50mg |
48.3mg |
-3.4% |
96.08% |
Lab C |
| 23 May 2026 |
MOTS-C |
4.7 |
30mg |
33.8mg |
+12.8% |
98.45% |
Lab F |
| 23 May 2026 |
Superdrol |
5.5 |
20mg |
19.7mg |
-1.3% |
99.94% |
Lab D |
| 23 May 2026 |
S-23 Raw |
4.0 |
10g |
8.9g |
-10.5% |
98.68% |
Lab A |
| 21 May 2026 |
AA Water |
4.1 |
30mg |
31.8mg |
+6.0% |
98.25% |
Lab E |
| 21 May 2026 |
Aromasin (Exemestane) |
4.8 |
20mg |
22.5mg |
+12.3% |
96.52% |
Lab D |
| 20 May 2026 |
Phenylacetic acid CAS 103-82-2 |
5.3 |
5g |
5.8g |
+15.1% |
97.08% |
Lab B |
| 20 May 2026 |
Testosterone Base Micro Raw |
4.1 |
100g |
98.5g |
-1.5% |
97.60% |
Lab G |
| 26 Jan 2026 |
Testosterone Cypionate Raw |
4.8 |
1g |
0.9g |
-6.0% |
96.29% |
Lab E |
| 19 Jan 2026 |
Humanin |
4.0 |
30mg |
32.7mg |
+9.2% |
95.43% |
Lab D |
| 9 Jan 2026 |
Adipotide |
4.0 |
2mg |
2.2mg |
+10.3% |
99.81% |
Lab F |
| 9 Jan 2026 |
BAM15 |
4.1 |
50mg |
45.4mg |
-9.3% |
97.62% |
Lab A |
| 7 Jan 2026 |
ACE-031 |
4.3 |
10mg |
10.4mg |
+4.1% |
97.98% |
Lab F |
| 6 Jan 2026 |
ARA-290 |
4.0 |
30mg |
29.9mg |
-0.3% |
99.50% |
Lab F |
| 6 Jan 2026 |
Dapoxetine |
5.5 |
25mg |
31.2mg |
+24.8% |
96.57% |
Lab B |
| 6 Jan 2026 |
Testosterone Propionate Raw |
4.3 |
10g |
10.1g |
+0.5% |
96.18% |
Lab F |
| 29 Dec 2025 |
DHB (1-Test Cyp) Oral |
4.0 |
25mg |
24.9mg |
-0.6% |
97.24% |
Lab C |
| 29 Dec 2025 |
NAD+ Injectable |
4.0 |
200mg/ml |
222.2mg/ml |
+11.1% |
95.49% |
Lab E |
| 29 Dec 2025 |
Retatrutide 30mg Pen Kit |
4.2 |
20mg |
17.4mg |
-13.1% |
97.50% |
Lab G |
| 29 Dec 2025 |
Selank 10mg + Semax 10mg Blend |
4.6 |
2mg |
1.8mg |
-7.8% |
95.02% |
Lab E |
| 12 Dec 2025 |
Turinabol |
4.3 |
10mg |
11.0mg |
+10.1% |
96.08% |
Lab C |
| 5 Dec 2025 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
4.0 |
1g |
0.9g |
-11.0% |
97.95% |
Lab F |
| 23 Nov 2025 |
BPC-157 Arg Oral |
4.0 |
100mg |
108.7mg |
+8.7% |
99.34% |
Lab F |
| 23 Nov 2025 |
Hyaluronic acid |
5.8 |
10mg |
9.7mg |
-3.0% |
96.82% |
Lab D |
| 23 Nov 2025 |
Selank |
4.0 |
5mg |
6.0mg |
+19.1% |
98.70% |
Lab F |
| 17 Nov 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.8 |
20mg |
21.0mg |
+4.8% |
98.93% |
Lab E |
| 17 Nov 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
4.0 |
50mg |
57.0mg |
+13.9% |
99.60% |
Lab E |
| 5 Nov 2025 |
17a-Methyl-1-Testosterone |
5.0 |
100mg |
92.7mg |
-7.3% |
99.88% |
Lab E |
| 5 Nov 2025 |
Cerebrolysin |
4.0 |
30mg |
28.9mg |
-3.8% |
99.59% |
Lab A |
| 4 Nov 2025 |
SS-31 (Elamipretide) Raw |
4.2 |
500g |
583.9g |
+16.8% |
96.07% |
Lab B |
| 17 Oct 2025 |
Testosterone Phenylpropionate Raw |
4.4 |
5g |
5.1g |
+1.8% |
98.49% |
Lab E |
| 9 Oct 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
4.0 |
50mg |
46.0mg |
-7.9% |
99.62% |
Lab B |